Cardiac amyloidosis (CA) is an increasingly recognized cause of heart failure (HF) and mortality, resulting from the progressive deposition of misfolded proteins (1, 2), mainly immunoglobulin light chains (AL) and transthyretin (ATTR) (3). This evidence concerns the gene TTR and cardiac amyloidosis.